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Abstract
Background—The mechanisms underlying the co-occurrence of the functional somatic
syndromes are largely unknown. No empirical study has explicitly examined how genetic and
environmental factors influence the comorbidity of these syndromes. We aimed to examine how
the comorbidity of functional somatic syndromes is influenced by genetic and environmental
factors that are in common to the syndromes.
Methods—A total of 31,318 twins in the Swedish Twin Registry aged 41–64 underwent
screening interviews via a computer-assisted telephone system from 1998 to 2002. Four functional
somatic syndromes (chronic widespread pain, chronic fatigue, irritable bowel syndrome, and
recurrent headache) and 2 psychiatric disorders (major depression and generalized anxiety
disorder) were assessed using structured questions based on standard criteria for each illness in a
blinded manner.
Results—Multivariate twin analyses revealed that a common pathway model with 2 latent traits
that were shared by the 6 illnesses fit best to the women's data. One of the 2 latent traits loaded
heavily on the psychiatric disorders, whereas the other trait loaded on all 4 of the functional
somatic syndromes, particularly chronic widespread pain, but not on the psychiatric disorders. All
illnesses except the psychiatric disorders were also affected by genetic influences that were
specific to each.
Conclusions—The co-occurrence of functional somatic syndromes in women can be best
explained by affective and sensory components in common to all these syndromes, as well as by
unique influences specific to each of them. The findings clearly suggest a complex view of the
multifactorial pathogenesis of these illnesses.
INTRODUCTION
It is a general observation in clinical practice that patients with persistent pain or fatigue
frequently have comorbid symptoms that show similar clinical features. These symptoms or
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syndromes include fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and
recurrent headache. An increasing literature has revealed that considerable overlap (Aaron &
Buchwald, 2001) exists among these illnesses, which are often referred to as functional
somatic syndromes (Barsky & Borus, 1999; Henningsen, Zipfel, & Herzog, 2007; Wessely,
Nimnuan, & Sharpe, 1999), although there is no consensus definition or criteria. These
syndromes also share characteristics such as a female predominance and frequent co-
occurrence with psychiatric disorders, most notably major depression and generalized
anxiety disorder.
In our previous report (Kato, Sullivan, Evengard, & Pedersen, 2006a), we demonstrated
elevated risks of comorbidity with chronic widespread pain in the general population.
Furthermore, the extent to which the observed associations are influenced by familial (i.e.,
genetic and environmental) factors may be illness-specific. Nevertheless, the etiological
structure in the mechanisms underlying the co-occurrence of these syndromes remains
unknown. Typically, the discussion over functional somatic syndromes can be characterized
as reflecting conceptualizations from “lumpers” and “splitters” (Deary, 1999; Wessely &
White, 2004): The former tend to emphasize the commonalities among the syndromes,
whereas the latter tend to emphasize the distinctness of each syndrome. Some studies
support the notion that these syndromes can be clustered, by using statistical modeling
(Ciccone & Natelson, 2003; Nimnuan, Rabe-Hesketh, Wessely, & Hotopf, 2001;
Nisenbaum, Reyes, Unger, & Reeves, 2004). On the other hand, various studies have found
differences among the syndromes (Evengard et al., 1998; Moss-Morris & Spence, 2006;
Parker, Wessely, & Cleare, 2001; Romans, Belaise, Martin, Morris, & Raffi, 2002). Thus, at
issue is to investigate the balance between splitting and lumping views of these syndromes
(Henningsen et al., 2007). To date, no empirical study has explicitly examined whether and
to what extent functional somatic syndromes can be attributable to one or a few factors in
common to the syndromes, and how important genetic and environmental influences are for
the common factor(s), if any.
The present study employed a quantitative genetic approach using twins, a valuable source
of information about genetic and environmental bases of complex disorders (Boomsma,
Busjahn, & Peltonen, 2002). The twins were ascertained from the population-based Swedish
Twin Registry, which enabled us to minimize selection biases to which clinical samples are
prone (e.g., those seeking medical care tend to have more concurrent disorders). By using
the same population-based sample as in our previous report (Kato et al., 2006a), we aimed in
this study to evaluate the multivariate structure of genetic and environmental factors for the
comorbidities of 4 most common functional somatic syndromes (chronic widespread pain,
chronic fatigue, irritable bowel syndrome, and recurrent headache) and 2 psychiatric
disorders (major depression and generalized anxiety disorder), all of which were assessed
via standard criteria. Based on our previous findings (Kato et al., 2006a), we already know
that the co-occurrence of these illnesses are influenced, in part, by familial factors that are
shared among them. However, we now will be able to go further and reveal the structure and
relative importance of genetic and environmental influences for the co-occurrence.
METHODS
Subjects
Subjects were participants in the Swedish Twin Registry, which comprises all twin births in
Sweden from 1886 to 2000, with data on place of birth, current vital status, and address of
more than 160,000 individuals (Lichtenstein et al., 2002; Lichtenstein et al., 2006). All
living, contactable, and consenting twins born in Sweden between January 1935, and
December 1958 were interviewed via the telephone from March 1998 to December 2002.
Thus, the interviewees were between 41 and 64 years of age at the time of the interview. The
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interviews were conducted by trained personnel with adequate medical background using a
computer based data collection system. All participants provided verbal informed consent
during this telephone interview which was later confirmed by postcard. Zygosity was based
on responses to questions regarding physical similarity in childhood. This method has been
validated repeatedly as having 98% or higher accuracy by using DNA markers (Lichtenstein
et al., 2002). This study was approved by the ethical committee of Karolinska Institutet.
Assessment Procedures
Chronic widespread pain was defined using our previously reported algorithm (Kato et al.,
2006a; Kato, Sullivan, Evengard, & Pedersen, 2006b) based on the classification criteria for
fibromyalgia proposed by the American College of Rheumatology (Wolfe et al., 1990)
without clinical examinations. Interviewees were asked about continuous pain during 3
consecutive months in both the upper and lower body and in both the right and left sides of
the body. Those who further endorsed pain on body axis (assessed as back pain in the last 12
months) in addition to the previous questions were defined as chronic widespread pain
cases. Detailed information about the criteria for chronic widespread pain in this study was
reported elsewhere (Kato et al., 2006b).
Screening of chronic fatigue was based on our criteria that emulated closely the 1994 criteria
for chronic fatigue syndrome (Fukuda et al., 1994) without clinical examinations. We
defined fatigue as the presence of self-reported abnormal tiredness in the absence of an
exclusionary condition. Exclusionary conditions were determined from multiple sources
(e.g., Swedish national registers and medical records), as described elsewhere (Evengard,
Jacks, Pedersen, & Sullivan, 2005). Subjects were considered having chronic impairing
fatigue when they endorsed that they had felt abnormally tired in the last 6 months and that
they experienced impairment. The definition of chronic impairing fatigue corresponds to
“CF-B” in our previous report (Evengard et al., 2005).
Irritable bowel syndrome was assessed by criteria used in previous studies in the Swedish
Twin Registry (Svedberg, Johansson, Wallander, Hamelin, & Pedersen, 2002), which is in
line with the Rome criteria (Thompson, Dotevall, Drossman, Heaton, & Kruis, 1989). In
brief, subjects who endorsed experiencing recurrent discomfort in the stomach or intestine at
least 7 days per month with one of the 6 symptoms were defined as having irritable bowel
syndrome.
A lifetime history of recurrent headache not associated with infection, fever, or hangover
was assessed through the stem question, “Do you or have you ever suffered from recurrent
headaches, that were not caused by infection, fever, or hangovers?”, which has been used in
previous studies in the Swedish Twin Registry (Svensson, Waldenlind, Ekbom, & Pedersen,
2004).
Major depression and generalized anxiety disorder were assessed by using the Computerized
Composite International Diagnostic Interview-Short Form (CIDI-SF) adapted from its
original design for 12-month prevalence to assess lifetime prevalence (Kessler, Andrews,
Mroczek, Ustun, & Wittchen, 1998). Details on these criteria were described elsewhere
(Kendler, Gatz, Gardner, & Pedersen, 2006b; Mackintosh, Gatz, Wetherell, & Pedersen,
2006).
Statistical Analyses
Patterns of similarity in monozygotic and dizygotic pairs are the basis of inferences
regarding the likely importance of genetic and family environmental influences. Because
monozygotic twins share all their genes and dizygotic twins share only half (of their
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segregating genes) on average, comparison of similarities in monozygotic and dizygotic
twins permits estimating the relative importance of genes and environment. Using structural
equation modeling, individual differences in liability to disease may be decomposed into 3
latent sources of variation: additive genetic, shared environmental, and nonshared
environmental variance. Additive genetic influences are indicated when monozygotic twins
are more similar than dizygotic twins. Shared (family) environmental influences
(environmental influences that make family members similar) contribute equally to the
similarity of monozygotic and dizygotic twins. Nonshared (unique) environmental
influences, which contribute to the dissimilarity of twins, include measurement errors as
well. As a preliminary analysis, we first calculated phenotypic tetrachoric correlations
stratified by sex, using the PROC FREQ procedure in SAS statistical software version 9
(SAS Institute, Inc, Cary, NC).
The models examined in this study are based on a liability threshold model (Falconer, 1965).
We examined 3 types of model, each of which depicts a particular hypothesis about genetic
and environmental structure for comorbidities. FIGURE 1 illustrates these 3 models, in
which 4 variables for each are included for simplicity. First, we examined a Cholesky
decomposition (also known as a triangular decomposition) model, which included additive
genetic (A), shared environmental, and nonshared environmental (E) components (Figure
1a). In a Cholesky model, the first factor loads on all the variables, the second factor loads
on all but the first one, and so on. Second, we examined an independent pathway model
which included 1 common factor of genetic and environmental components, as well as
unique factors for each variable (Figure 1b). Third, we examined a common pathway model,
where all variables were influenced by a single latent factor that was itself influenced by
genetic and environmental components (Figure 1c). We further extended our analysis of
common pathway models with 2 (Figure 1d) and 3 latent factors. We compared the
Cholesky model, independent pathway model, and common pathway models with 1 to 3
latent factors in terms of Akaike Information Criterion (AIC) (Akaike, 1987). A smaller,
more negative value of AIC indicates that the model fits the data better than other models
with a greater AIC. Maximum likelihood model fitting was applied to raw data, by using the
Mx program (Neale, Boker, Xie, & Maes, 2004). In all analyses, we adjusted trait
prevalence (threshold of liability to each illness) for age at the interview and sex using
logistic regression coefficients computed by the PROC LOGISTIC procedure in SAS.
Standardized path coefficients were obtained by fixing the total variance of each variable as
well as the variance of latent factors (in common pathway models) to be unity. Through an
iterative procedure, we ran each model 6 times, using parameter estimates for one model as
the starting values for the next model, and picked the model with the best fit (typically the
last).
RESULTS
Of 41,355 eligible individuals under 65 years of age, 31,318 responded to the interview.
Both members of 12,248 twin pairs (24,496 pair-wise respondents) and 6,822 single
respondents were included. Of the pair-wise respondents, 3,260 pairs were monozygotic,
4,470 pairs same-sexed dizygotic, 4,518 pairs opposite-sexed dizygotic, and 127 pairs of
unknown zygosity. The mean age ± standard deviation of the sample at the time of the
interview was 53.7 ± 5.7 years, and 53.1% were women.
TABLE 1 summarizes the prevalence estimates for the 4 functional somatic syndromes and
the 2 psychiatric disorders. Recurrent headache showed the highest prevalence both in
women and men, followed by major depression. TABLE 2 shows phenotypic associations
(tetrachoric correlations) stratified by sex. The pattern of correlations was generally similar
in men and women. The strongest associations were between chronic widespread pain and
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chronic impairing fatigue, and between generalized anxiety disorder and major depression.
Most other associations were moderate, and all were significantly greater than zero (P < .
001). Due to the scarcity of male pairs concordant for 2 of the syndromes, only women were
used in the subsequent analyses.
In the model fitting (TABLE 3), we first tested each model by dropping shared
environmental factors, resulting in no significant changes in fit. Thus, only additive genetic
factors (A) and nonshared environmental factors (E) were included in the models thereafter
(“AE models”). When we compared the 5 models (i.e., models a, b, c(i), c(ii), and c(iii) in
Table 3) in terms of AIC, the 2-factor common pathway model c(ii) fit best, i.e., had the
smallest AIC. We then dropped non-significant paths from the 2-factor common pathway
model in order to obtain the most parsimonious model (FIGURE 2). Dropping the paths
from A1 and E1 to the second latent factor L2 did not significantly worsen the goodness-of-
fit (c(ii)' in Table 3), indicating that these 2 latent factors are independent of each other both
genetically and environmentally. The first latent factor L1 was more greatly influenced by
genetic factor A1 than by environmental factor E1, whereas L2 was slightly more influenced
by environmental factor E2 than by genetic factor A2. Only L1 loaded on major depression
and generalized anxiety disorder. In addition, paths from unique genetic factors to these
disorders were not significant, suggesting that genetic influences on major depression and
generalized anxiety disorder can be accounted for by the common genetic factor A1 through
L1. On the other hand, L2 loaded primarily on chronic widespread pain, followed by chronic
impairing fatigue. For all 4 functional somatic syndromes, the loading from L2 was greater
than that from L1. The proportion of variance explained by the 2 latent factors was 74%
(=0.292 + 0.812) for chronic widespread pain, 54% for chronic impairing fatigue, 31% for
irritable bowel syndrome, and 20% for recurrent headache. Note that the loadings from L1
and L2 were standardized for each variable, which means that the values of path coefficients
indicate the relative importance for liability to each syndrome or disorder and should not be
interpreted as reflecting the actual magnitude of the impacts of L1 and L2.
DISCUSSION
In this large, population-based study using a genetically informative sample of women, we
found that the co-occurrence of functional somatic syndromes (chronic widespread pain,
chronic impairing fatigue, irritable bowel syndrome, and recurrent headache) is due to
combined effects of 2 latent traits: One of the traits is predominantly defined as psychiatric
and more influenced by genetic factors, whereas the other is not related to psychiatric
disorders but particularly to chronic widespread pain and is more influenced by
environmental factors. In addition, we found that each syndrome is also influenced by
genetic and environmental factors that are specific to each. To our knowledge, the present
study is the first to reveal the structure and relative importance of genetic and environmental
influences on complex etiological mechanisms underlying the comorbidities of as yet
unexplained functional somatic syndromes.
Researchers have widely debated whether the illnesses known as functional somatic
syndromes can be clustered as a single, either physical or mental disorder, or each of these
illnesses should be considered as a distinct entity (Wessely & White, 2004). The empirical
evidence for women provided by the present study demonstrates the entire etiological
structure wherein both psychiatric and non-psychiatric (or physical) traits influence the co-
occurrence. Both the latent traits in common to all the syndromes and those factors unique to
each syndrome play some role. Furthermore, the relative importance of the 2 latent traits for
the syndromes varies from illness to illness, ranging between 20% (recurrent headache) and
74% (chronic widespread pain). Our findings suggest a possible solution to controversies
over the pathogenesis of functional somatic syndromes. That is, these syndromes co-occur
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because they share 2 etiological components, whereas the syndromes are distinguishable
because factors unique to each are also important. Given that these unique factors are
predominantly environmental for all the syndromes except chronic widespread pain (Figure
2), it is likely that differences in symptoms and characteristics observed in each syndrome
are primarily due to non-familial, environmental influences experienced by each individual.
Collectively, the results in this study lend support for multifactorial pathogenesis in both the
etiology of the syndromes and their co-occurrence.
Latent trait L1, which is common to all 6 illnesses, indicates that functional somatic
syndromes share underlying mechanisms in part with major depression and generalized
anxiety disorder. The present finding that these psychiatric disorders contribute to the
associations among the functional somatic syndromes through a latent trait with a substantial
genetic loading is consistent with our previous findings on the association between major
depression, generalized anxiety disorder, and chronic widespread pain (Kato et al., 2006a).
Given that emotional instability is a predictor of depression (Kendler, Gatz, Gardner, &
Pedersen, 2006a), the present results are also in line with findings that the association
between premorbid emotional instability and chronic fatigue was mediated by genetic
factors (Kato, Sullivan, Evengard, & Pedersen, 2006c). Furthermore, our recent study has
demonstrated that premorbid emotional instability is a predictor of not only chronic fatigue
but also chronic widespread pain and other related symptoms, and that these prospective
associations are partly mediated by genetic influences (Charles, Gatz, Kato, & Pedersen, in
press). Taking into consideration these longitudinal studies as well as the present study,, the
latent trait L1 is likely related to the predisposition to these psychiatric disorders, and the
genetic factor A1 is likely a set of genes responsible for its biological mechanisms, e.g.,
serotonin transporter genes (Camilleri et al., 2002; Juhasz et al., 2003; Narita et al., 2003;
Offenbaecher et al., 1999). Similarly, environmental factor E1 may be individual
experiences such as stressful life events and social learning. It should be of note, however,
that the present results do not mean that psychiatric disorders cause functional somatic
syndromes, but rather that these illnesses are likely to share psychobiological pathways in
the pathogenesis, e.g., responses to stress or regulatory mechanisms in the brain.
We found a distinct, second latent trait L2, which itself is more influenced by environmental
factors than by genetic ones. Given the substantial loading of L2 on chronic widespread
pain, we speculate that this trait is related primarily to pain sensation without its affective
dimension. Exaggerated pain is common in patients with fibromyalgia (Price et al., 2002;
Staud, Vierck, Cannon, Mauderli, & Price, 2001), and studies have consistently supported
the contribution of central mechanisms to pain hypersensitivity (Staud & Smitherman,
2002). Abnormalities of central pain processing similar to fibromyalgia have also been
observed in patients with irritable bowel syndrome (Verne & Price, 2002) and recurrent
headache (Okifuji, Turk, & Marcus, 1999), although the evidence for central sensitization in
chronic fatigue is limited. These findings suggest abnormal pain processing in the central
nervous system as a plausible pathophysiologic characteristic in common to functional
somatic syndromes. In addition, a study using brain imaging for fibromyalgia patients
showed that neither the presence nor the level of depression modulated the sensory
dimension of pain; however, depression was associated with neuronal activation in brain
regions processing the affective dimension of pain, suggesting that pain in fibromyalgia is
regulated by the two distinct, affective and sensory dimensions (Giesecke et al., 2005).
Thus, the 2 latent traits can be considered analogous to the 2 dimensions of pain and we
propose our model be called the “affective-sensory model” of functional somatic syndromes.
The present study has notable strengths such as using a genetically informative sample of
twins who can be considered a representative of Swedish population. In addition, 4 major
functional somatic syndromes and 2 psychiatric disorders were assessed by using a
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structured interview in a blinded manner, which allows us to minimize recall and
interviewer biases. Furthermore, the final best-fit model was selected through a series of
statistical tests in a conventional manner, which is free from a priori knowledge or biases
due to investigators' medical specialty (Wessely et al., 1999). Nevertheless, some limitations
should also be noted. First, our assessment was based on self-reports via telephone
interviews, without physical examinations by a physician. Thus, the results may not be
directly comparable to those using clinical samples. Second, the data were obtained on only
one occasion, although some of the illnesses were diagnosed as lifetime occurrence. Thus,
temporal order is unclear. Third, our study design does not preclude the possibility that
subjects with these syndromes were heterogeneous and could be categorized into subgroups.
For example, the influences of L2 on chronic fatigue may reflect subgroups of subjects who
suffered from joint and muscle pain as well as fatigue. To answer this question, further
investigations using statistical techniques such as latent class analysis will be needed
(Sullivan, Pedersen, Jacks, & Evengard, 2005). Fourth, it is possible that the proportion of
measurement error in the estimates of specific environmental influences (Eu) differs from
illness to illness. Thus, care should be taken when comparing estimates for Eu between or
across the illnesses examined. Finally, gene-environment interaction was not addressed in
the present analyses. Thus, the estimates reported here may be regarded as a first
approximation of the relative contributions of genetic and environmental influences.
In conclusion, the co-occurrence of functional somatic syndromes can be best explained by
distinct affective and sensory components that impact all these syndromes, as well as by
influences specific to each. The findings suggest that a complex view of the multifactorial
pathogenesis of these illnesses is clearly required.
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Examples of models for underlying structures of comorbidities (multivariate AE models).
A: additive genetic factors; E: nonshared environmental factors. L: latent factor. Factors
with a subscript “u” are unique to each syndrome. For simplicity, only one twin of a pair is
shown and shared environmental factors are excluded.
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Best-fit (2-factor common pathway) model with age-adjusted, standardized parameter
estimates for the 6 illnesses in women aged 41–64.
A: additive genetic factors; E: nonshared environmental factors. Factors with a subscript “u”
are unique to each illness. L1, L2: latent factors. MD: major depression. GAD: generalized
anxiety disorder. IBS: irritable bowel syndrome. CF: chronic impairing fatigue. CWP:
chronic widespread pain. The total variances of L1 and L2 as well as each variable were
fixed at 1. Non-significant paths were dropped from the model. For simplicity, only one twin
of a pair is shown.
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